{"product_id":"rheumnow-live-2026","title":"RheumNow Live 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: rheumatologists and immunologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eRheumNow Live 2026 provides a comprehensive and cutting-edge clinical update on rheumatology and autoimmune diseases. The program features expert insights into the diagnosis, management, and emerging therapies for conditions such as rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, and gout, along with specialized updates on vasculitis, osteoporosis, and osteoarthritis.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate recent advances in the diagnosis and management of rheumatoid arthritis, including interstitial lung disease (ILD) complications and the mucosal hypothesis.\u003c\/p\u003e\n\u003cp\u003eAnalyze the evolving treatment landscapes for systemic autoimmune conditions such as large and small vessel vasculitis and Sjögren’s syndrome.\u003c\/p\u003e\n\u003cp\u003eAssess the impact of patient comorbidities, including obesity and inflammation, and apply risk mitigation strategies for rheumatic patients undergoing orthopedic surgery.\u003c\/p\u003e\n\u003cp\u003eIdentify emerging therapeutic options and mechanisms of action presented in clinical showcases for advanced rheumatic disease management.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for rheumatologists and immunologists who want updates on rheumatoid arthritis, spondyloarthritis, and emerging autoimmune therapies.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e2026 Advances in Spondyloarthritis\u003c\/p\u003e\n\u003cp\u003eAdvancing Practice Faculty QA\u003c\/p\u003e\n\u003cp\u003eAsymptomatic Elevation of CK\u003c\/p\u003e\n\u003cp\u003eAutoimmune Faculty QA\u003c\/p\u003e\n\u003cp\u003eClosing Comments Adjourn\u003c\/p\u003e\n\u003cp\u003eDiagnosing Axial Spondyloarthritis in 2026\u003c\/p\u003e\n\u003cp\u003eDisease Modification in Osteoarthritis\u003c\/p\u003e\n\u003cp\u003eEmbracing Relapses in PMR and GCA\u003c\/p\u003e\n\u003cp\u003eHelicobacter Pylori Update\u003c\/p\u003e\n\u003cp\u003eHighlights in Autoimmune Disease\u003c\/p\u003e\n\u003cp\u003eHistory of Gout\u003c\/p\u003e\n\u003cp\u003eILD in RA – Recent Advances\u003c\/p\u003e\n\u003cp\u003eLarge Small Vessel Vasculitis\u003c\/p\u003e\n\u003cp\u003eMitigating Risk for Rheumatic Disease Patients Undergoing Orthopedic Surgery\u003c\/p\u003e\n\u003cp\u003eMortality in Rheumatoid Arthritis A Story of Decline Delay or Plateau\u003c\/p\u003e\n\u003cp\u003eObesity and Inflammation Weight Management in Rheumatology\u003c\/p\u003e\n\u003cp\u003eOsteoporosis A 50 Year Journey\u003c\/p\u003e\n\u003cp\u003eParadoxical Psoriasis and Strange Reactions\u003c\/p\u003e\n\u003cp\u003ePast Present Future of Gout\u003c\/p\u003e\n\u003cp\u003ePlacebos in Rheumatology\u003c\/p\u003e\n\u003cp\u003ePod 1 Rheumatoid Arthritis Achieving Better Outcomes\u003c\/p\u003e\n\u003cp\u003ePOD 2 Advancing Practice\u003c\/p\u003e\n\u003cp\u003ePOD 3 Decisions in Psoriatic Arthritis\u003c\/p\u003e\n\u003cp\u003ePost-Reception Performance\u003c\/p\u003e\n\u003cp\u003ePsoriatic Arthritis Faculty QA\u003c\/p\u003e\n\u003cp\u003eRheumatoid Arthritis Faculty QA\u003c\/p\u003e\n\u003cp\u003eSjogrens Treatment Landscape in 2026\u003c\/p\u003e\n\u003cp\u003eSmall Vessel Vasculitis\u003c\/p\u003e\n\u003cp\u003eSMILE Study – Hydroxychloroquine in ANA Arthralgia\u003c\/p\u003e\n\u003cp\u003eSpondyloarthritis Complications\u003c\/p\u003e\n\u003cp\u003eSpondyloarthritis Faculty QA\u003c\/p\u003e\n\u003cp\u003eStaying Ahead of Spondyloarthritis\u003c\/p\u003e\n\u003cp\u003eThe Mucosal Hypothesis of Rheumatoid Arthritis\u003c\/p\u003e\n\u003cp\u003eUpdate on Myositis Antibodies\u003c\/p\u003e\n\u003cp\u003eVasculitis Faculty QA\u003c\/p\u003e\n\u003cp\u003eVIRTUAL SHOWCASE AMGEN\u003c\/p\u003e\n\u003cp\u003eVIRTUAL SHOWCASE Eli Lilly\u003c\/p\u003e\n\u003cp\u003eVIRTUAL SHOWCASE Genentech\u003c\/p\u003e\n\u003cp\u003eVIRTUAL SHOWCASE Sanofi\u003c\/p\u003e\n\u003cp\u003eWelcome Introduction 2\u003c\/p\u003e\n\u003cp\u003eWelcome Introduction\u003c\/p\u003e\n\u003cp\u003eWhy Do Plain Xrays in Psoriatic Arthritis\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405748916420,"sku":null,"price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/RheumNow-Live-2026.jpg?v=1784215582","url":"https:\/\/medicalcoursespro.com\/products\/rheumnow-live-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}